Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_6035_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •About the Editor
- •Contents
- •Contributors
- •Abbreviations
- •Preface
- •1. Natural Products as Drug Candidates
- •1.1 Introduction
- •1.2 An array of natural products
- •1.2.1 Plant-derived natural products
- •1.2.2 Microbial natural products
- •1.3 Importance of analytical techniques
- •1.3.1 A glance at extraction techniques
- •1.3.2 Microbial culturing techniques
- •1.3.3 Outlook and perspectives in nanoparticles
- •1.4 Natural products as a guide in drug design and synthesis
- •1.5 Natural products as promising drug candidates
- •1.5.1 Antiviral drug candidates
- •1.5.2 Antiparasitic drug candidates
- •1.5.3 Neuroprotective agents
- •1.6 Conclusion
- •Keywords
- •References
- •2. Traditional Knowledge for Drug Discovery
- •2.1 Introduction
- •2.2 Databases on indian remedial flora, indigenous medicines, and phytochemicals
- •2.2.1 Cultural preservation
- •2.2.2 Sustainable practices
- •2.2.3 Biodiversity conservation
- •2.2.4 Health and medicine
- •2.2.5 Climate change adaptation
- •2.2.6 Interconnectedness and wisdom
- •2.3 History of traditional knowledge
- •2.3.1 Indigenous healing practices
- •2.3.2 Aboriginal dreamtime
- •2.3.3 Traditional agriculture
- •2.3.4 Traditional crafts
- •2.3.5 Indigenous cosmologies
- •2.3.6 Traditional music and dance
- •2.3.7 Traditional navigation
- •2.4 Traditional medicine in plant formulations
- •2.4.1 Ayurveda
- •2.4.2 Traditional chinese medicine
- •2.4.3 Indigenous healing practices
- •2.5 Drug discovery
- •2.6 Aspects of developing plant-based drugs
- •2.6.1 Selection criteria for plants
- •2.6.2 Plant material authentication
- •2.6.3 Extraction methods
- •2.6.4 Isolation and structure elucidation of bioactive components
- •2.6.5 Standardization of plant formulations
- •2.7 Conclusions
- •References
- •3. Herbal Healing: Plant-Based Natural Products
- •3.1 Introduction
- •3.2 Classification of secondary metabolites
- •3.2.1 Phenolic compounds
- •3.2.2 Terpenes
- •3.2.3 Alkaloids
- •3.3 History of natural products
- •3.4 Drug discovery from natural products
- •3.5 Drugs derived from the plants
- •3.6 Conclusions
- •Keywords
- •References
- •4. Natural Products with Antimicrobial Properties
- •4.1 Introduction
- •4.2 Plants as antimicrobial agents
- •4.3 Marine sources as antimicrobial agents
- •4.4 Antimicrobial products derived from microorganisms
- •4.5 Conclusions and future trends
- •Keywords
- •References
- •5. Natural Products with Immunomodulatory Properties
- •5.1 Introduction
- •5.2.1 Aloe vera (l.) burm.f. (family: asphodelaceae)
- •5.2.2 Andrographis paniculata (burm. f.) wall.ex.nees. (family: acanthaceae)
- •5.2.3 Acorus calamus l. (family: araceae)
- •5.2.4 Allium sativum l. (family: alliaceae)
- •5.2.5 Azadirachta indica a. juss. (family: meliaceae)
- •5.2.6 Argyreia speciosa (l.f.) sweet (family: convolvulaceae)
- •5.2.7 Bidens pilosa l. (family: asteraceae)
- •5.2.8 Baliospermum montanum (willd.) müll.arg. (family: euphorbiaceae)
- •5.2.9 Boerhaavia diffusa l. (family: nyctaginaceae)
- •5.2.10 Boswellia serrata roxb. excolebr. (family: burseraceae)
- •5.2.11 Camellia sinensis (l.) kuntze (family: theaaceae)
- •5.2.12 Capparis zeylanica l. (family: capparidaceae)
- •5.2.13 Calendula officinalis l. (family: asteraceae)
- •5.2.14 Chelidonium majus l. (family: papaveraceae)
- •5.2.15 Carica papaya l. (family: caricaceae)
- •5.2.26 Glycyrrhiza glabra l. (family: leguminosae)
- •5.2.27 Hypericum perforatum l. (family: hypericaceae)
- •5.2.28 Hippophae rhamnoides l. (family: elaeagnaceae)
- •5.2.29 Hydrastis canadensis l. (family: ranunculaceae)
- •5.2.30 Jatropha curcas l. (family: euphorbiaceae)
- •5.2.31 Mangifera indica l. (family: anacardiaceae)
- •5.2.32 Mollugo verticillata l. (family: molluginaceae)
- •5.2.33 Matricaria chamomilla l. (family: asteraceae)
- •5.2.34 Momordica charantia l. (family: cucurbitaceae)
- •5.2.35 Morinda citrifolia l. (family: rubiaceae)
- •5.2.36 Nigella sativa l. (family: ranunculaceae)
- •5.2.37 Nelumbo nucifera gaertn. (family: nymphaeceae)
- •5.2.38 Nerium oleander l. (family: apocynaceae)
- •5.2.39 Ocimum tenuiflorum l. (family: labiatae)
- •5.2.40 Premna tomentosa willd. (family: verbanaceae)
- •5.2.41 Plantago sp. (plantago major l. and plantago asiatica l.) (family: plantaginaceae)
- •5.2.42 Psoralea corylifolia l. (family: fabaceae)
- •5.2.43 Prunella vulgaris l. (family: lamiaceae)
- •5.2.44 Punica granatum l. (family: punicaceae)
- •5.2.45 Rhinacanthus nasutus (l.) kurz (family: acanthaceae)
- •5.2.46 Salvia officinalis l. (family: lamiaceae)
- •5.2.47 Tamarindus indica l. (family: leguminosae)
- •5.2.48 Tinospora cordifolia (willd.) miers (family: menispermaceae)
- •5.2.16 Centella asiatica (l.) urb. (family: umbelliferae)
- •5.2.17 Cichorium intybus l. (family: asteraceae)
- •5.2.18 Cryptolepis dubia (burm.f.) m.r. almeida (family: apocynaceae)
- •5.2.19 Citrus aurantiifolia (christm.) swingle (family: rutaceae)
- •5.2.20 Curcuma longa l. (family: zingiberaceae)
- •5.2.21 Desmodium gangeticum (l.) dc. (family: fabaceae)
- •5.2.22 Eclipta prostrata (l.) (family: asteraceae)
- •5.2.23 Phyllanthus emblica l. (family: euphorbiaceae)
- •5.2.24 Evolvulus alsinoides (l.) (family: convolvulaceae)
- •5.2.25 Ficus benghalensis l. (family: moraceae)
- •5.2.49 Terminalia chebula retz. (family: combretaceae)
- •5.2.51 Urtica dioica l. (family: urticaceae)
- •5.2.52 Withania somnifera (l.) dunal (cultivated var.) (family: solanaceae)
- •5.3 Traditional importance of research to society and researchers
- •5.4 Conclusion
- •Keywords
- •References
- •6. Natural Products with Anticancerous Properties
- •6.1 Introduction
- •6.2 Plant-derived anticancer compounds
- •6.2.1 Polyphenols
- •6.2.2 Flavanoids
- •6.2.3 Brassinosteroids
- •6.2.4 Vinca alkaloids
- •6.2.5 Taxanes
- •6.2.6 Campothecin derivatives
- •6.3 Microorganisms-based anticancer compounds
- •6.3.1 Primary metabolites
- •6.3.2 Secondary metabolites
- •6.4 Selected medicinal plants with anticancerous activities
- •6.4.1 Curcuma longa l.
- •6.4.2 Viscum album l.
- •6.4.3 Colchicum autumnale l.
- •6.4.4 Raphanus sativus l.
- •6.4.5 Tinospora cordifolia wild
- •6.4.6 Nigella sativa l.
- •6.5 Therapeutic enzymes
- •6.6 Future perspective
- •6.7 Conclusion
- •Keywords
- •References
- •7. Natural Products with Antiviral Properties
- •7.1 Introduction
- •7.2 Source of natural products with antiviral activity
- •7.3 Main components of natural products
- •7.3.1 Flavonoids
- •7.3.2 Polyphenols
- •7.3.3 Polysaccharides
- •7.3.4 Terpenoids
- •7.4 Mechanisms of action of natural compounds in viral infections
- •7.4.1 Direct antiviral effect
- •7.4.2 Anti-inflammatory effect in viral infections
- •7.4.3 Effect on autophagy process
- •7.6 Conclusions
- •Keywords
- •References
- •8. Approaches to Develop Drugs from Natural Products
- •8.1 Introduction
- •8.2 Scenario of drug discovery
- •8.3 Efficient drug discovery engines
- •8.4 Drug discovery approaches using plants
- •8.4.1 Plant selection for screening purpose
- •8.4.2 Authentication of plants
- •8.4.3 Types of molecular markers
- •8.5.1 Parallel approach
- •8.5.2 Sequential approach
- •8.6 Structure elucidation of isolated compounds
- •8.7 Biological screening of extracts/fraction/isolates
- •8.7.1 Cell culture-based assay
- •8.7.2 Dialysis
- •8.7.3 Microdialysis
- •8.7.4 Ultrafiltration
- •8.7.5 Chromatography
- •8.7.6 Ligand fishing
- •8.8 Limitations
- •8.9 Molecular modelling and np database
- •8.10 Future thrust
- •8.11 Conclusion
- •Keywords
- •References
- •9. Strategies for Isolation and Identification of Bioactive Molecules from Natural Sources
- •9.1 Introduction
- •9.2 Bioactive compounds in natural sources and their pharmacological properties
- •9.3.1 Selection of materials
- •9.3.3 Types and properties of solvent for extraction
- •9.4 Extraction methods (conventional and modern)
- •9.4.1 Conventional methods
- •9.4.2 Novel extraction methods
- •9.5 Concentration and purification of bioactive molecules using chromatographic techniques
- •9.5.1 Separation based on adsorption properties
- •9.5.2 Separation based on partition coefficient
- •9.5.3 Separation based on the molecular size
- •9.5.4 Separation based on ionic strength
- •9.5.5 Other modern separation techniques
- •9.6 Identification and characterization of bioactive molecules
- •9.6.1 Qualitative and quantitative techniques/chromatographic or nonchromatographic techniques
- •9.7 Conclusions
- •Keywords
- •References
- •10. Role of Omics in Natural Product-Based Drug Discovery
- •10.1 Introduction
- •10.2 Genomics and transcriptomics in natural product discovery
- •10.2.1 Case studies and examples of natural product discovery using genomics and transcriptomics
- •10.2.2 Limitations and challenges of using genomics and transcriptomics in natural product discovery
- •10.3 Proteomics and metabolomics in natural product discovery
- •10.3.1 Case studies and examples of natural product discovery using proteomics and metabolomics
- •10.4 Bioinformatics in natural product-based drug discovery
- •10.4.1 Role of bioinformatics in natural product-based drug discovery
- •10.4.2 The use of bioinformatics to predict and annotate natural product biosynthetic pathways, gene clusters, and metabolomics
- •10.7 Future perspectives and potential impact of omics in natural product-based drug discovery
- •10.9 Potential impact on drug discovery and development
- •10.10 Conclusion
- •Keywords
- •References
- •11. Natural Products from Endophytic Microorganisms
- •11.1 Introduction
- •11.1.1 Rational/why endophytes?
- •11.2 Diversity of endophytic microorganisms
- •11.2.1 Endophytic bacteria and endophytic actinomycetes
- •11.2.2 Endophytic fungi
- •11.3.1 ISolation methods
- •11.3.1.1.1 Dilution Plating
- •11.3.1.1.2 Direct Plating
- •11.3.2 Identification methods
- •11.4 Bioactive compounds from endophytic microorganisms
- •11.4.1 Antibiotics
- •11.4.2 Antifungal agents
- •11.4.3 Antimalarial agents
- •11.4.4 Antiviral agents
- •11.4.5 Anticancer agents
- •11.4.6 Antioxidants
- •11.5 Stepwise methods for natural product discovery from endophytic microorganisms
- •11.5.1 Plant selection rationale
- •11.5.2 Isolation and cultivation of endophytes
- •11.5.3 Characterization of endophytes
- •11.5.4 Extraction of natural products
- •11.5.5 Purification of natural products
- •11.6 Biosynthesis and strategies for the optimization of natural product discovery from endophytic microorganisms
- •11.6.1 Exploration of novel microbial sources
- •11.6.2 Metabolomics-guided discovery
- •11.6.3 Coculture
- •11.6.4 Genome mining
- •11.6.5 Modulation by ultraviolent irradiation
- •11.7 Future directions and challenges
- •11.7.1 Improving the efficiency and accuracy of screening methods
- •11.7.2 Enhancing the scalability and affordability of production methods
- •11.7.3 Ensure natural product safety and efficacy
- •11.8 Conclusions
- •References
- •12. Natural Products with Antidiabetic Properties
- •12.1 Introduction
- •12.2 Natural products that regulate glucose absorption
- •12.2.1 Serotonin-derived products
- •12.2.2 Butyl-isobutyl-phthalate from laminaria japonica
- •12.2.3 Bioactive compounds of allium cepa and allium sativum
- •12.2.4 Elatosides E and F of aralia elata
- •12.2.5 Bioactive compounds of bauhinia candicans and bauhinia forficate
- •12.3 Natural products that enhance insulin sensitivity
- •12.3.1 Astragalus membranaceus polysaccharides
- •12.3.2 Bioactive compounds of litchi chinensis
- •12.3.3 Bioactive compounds of fenugreek
- •12.3.4 Bioactive compounds of cinnamon
- •12.3.5 Bioactive compounds of gastrodia elata
- •12.3.6 Polysaccharides of dioscorea
- •12.3.7 Anthocyanins of blueberries
- •12.3.8 Bioactive compounds of psidium guajava
- •12.4.1 Gingerol from zingiber officinale
- •12.4.2 Curcumin from curcuma longa
- •12.4.3 Berberine
- •12.4.4 Capsaicin of pepper
- •12.4.5 Bioactive compounds of bitter melon
- •12.4.6 Ginsenosides of ginseng
- •12.4.7 Bioactive compounds of aloe vera
- •12.4.8 Quinides of coffee
- •12.4.9 Bioactive compounds of tinospora cordifolia
- •12.4.10 Bioactive compounds of pterocarpus marsupium
- •12.4.11 Eugenol of ocimum sanctum
- •12.4.12 Bioactive compounds of syzygium densiflorum
- •12.5 Clinical trials based on antidiabetic effects of natural products derived from plants
- •12.5.1 Gymnema sylvestre (gurmar)
- •12.5.2 Fenugreek (trigonella foenum-graecum)
- •12.5.3 Tea catechins
- •12.5.4 Coffee
- •12.5.5 Rosemary (rosmarinus officinalis)
- •12.6 Conclusion
- •12.7 Future scope
- •Keywords
- •References
- •13. Marine-Derived Natural Products with Anticancer Properties
- •13.1 Introduction
- •13.2 Marine bioactive compounds
- •13.3 Anticancer activity of marine plants
- •13.4 Anticancer agents from marine floras
- •13.5.1 Antioxidants
- •13.5.2 Immunomodulation and apoptosis
- •13.5.3 Nutritional values and anticancer effects
- •13.6 Nature and cancer chemotherapy
- •13.7 Marine organisms and cancer chemotherapy
- •13.8 Anticancer agents from marine floras
- •13.9 Marine plants
- •13.9.1 Macro algae (seaweed)
- •13.9.2 Mangroves and other higher plants
- •13.9.3 Cyanobacteria
- •13.9.4 Bacteria
- •13.9.5 Proteobacteria
- •13.9.6 Cyanobacteria
- •13.9.7 Actinomycetes
- •13.9.8 Marine fungi
- •13.9.9 Soft corals
- •13.9.10 Marine sponges
- •13.10 Anticancer bioactive antibiotics derived from marine sources
- •13.10.1 Polyphenols
- •13.10.2 Polysaccharides
- •13.10.3 Alkaloids
- •13.11 Other marine sources for anticancer compounds
- •13.11.1 Peptides
- •13.11.2 Plitidepsin
- •13.11.3 Trabectedin
- •13.11.4 Lurbinectedin
- •13.12 Marine natural products as anticancer drugs
- •13.13.1 Aquaculture/cultivation
- •13.13.2 Genetic engineering
- •13.13.3 Synthesis/semisynthesis/modification
- •13.14 Conclusions and future prospects
- •References
- •14. Natural Products as Novel Opportunities for Cathepsin Inhibitors
- •14.1 Introduction
- •14.2 Cysteine proteases (CPs)
- •14.2.1 Cathepsin
- •14.2.2 Structure and mechanism of action of cathepsins
- •14.3 NPs as cathepsins inhibitors
- •14.3.1 NPs From bacteria as cathepsin inhibitors
- •14.3.2 NPs from fungus as cathepsin inhibitors
- •14.3.3 NPs from marine organism as cathepsin inhibitors
- •14.3.4 NPs from plants as cathepsin inhibitors
- •14.4 Conclusion and future pespectives
- •Keywords
- •References
- •15. Phytoestrogens in Drug Discovery: A Focus on Mechanisms of Action and Safety Assessment
- •15.1 Introduction
- •15.2 Phytoestrogens and estrogen receptors
- •15.3 Nonestrogen receptor-mediated effects of phytoestrogens
- •15.3.1 Mitogen-activated protein kinase (MAPK) pathway
- •15.3.2 PI3K/AKT pathway
- •15.3.3 WNT pathway
- •15.3.4 G-protein-coupled estrogen receptor (GPER)
- •15.4 Structure–activity relationship (SAR) of phytoestrogens
- •15.4.1 Isoflavones
- •15.4.2 Lignans
- •15.4.3 Coumestans
- •15.4.4 Stilbenes
- •15.4.5 Diarylheptanoids
- •15.5 Comparing potency and efficacy of phytoestrogens on various pathways
- •15.5.1 Potency and efficacy of phytoestrogens on different pathways
- •15.5.2 Possible synergistic effects of phytoestrogens with other drugs
- •15.6 Effects of phytoestrogens on the human organs
- •15.7 Safety Assessment of phytoestrogens
- •15.7.1 Toxicity assays used to evaluate the safety of phytoestrogens
- •15.7.2 Potential adverse effects of phytoestrogens
- •15.8 Case study
- •15.8.1 Vaginal cellular differentiation assay
- •15.8.2 Changes in rat body weight
- •15.8.3 Changes in rats’ uterus weight
- •15.9 Current trends in phytoestrogen research
- •15.9.1 Publication trends
- •15.9.2 Analysis of contributing countries and contributing institutions
- •15.9.3 Analysis of contributing publishers and journals
- •15.9.4 Publication evolution and research areas
- •15.9.5 Limitations
- •15.10 Future directions
- •15.10.1 Exploration of unexplored plant sources
- •15.10.2 Understanding mechanisms of action
- •15.10.3 Synthesis of novel compounds
- •15.10.4 Development of SPERMs
- •15.10.5 Safety assessment
- •15.11 Conclusion
- •Keywords
- •References
- •16. Honey Bee Products with Antimicrobial Properties
- •16.1 Introduction
- •16.2 Honey
- •16.3 Bee bread (perga)
- •16.4 Bee pollen
- •16.5 Bee propolis
- •16.6 Conclusion
- •Keywords
- •References
- •17. Natural Products for the Prevention of Leaky Gut
- •17.1 Introduction
- •17.2 The physical and chemical barriers of the intestine
- •17.2.1 Thick mucus layer
- •17.2.2 Intestinal epithelial cells (IECS)
- •17.2.3 Intestinal junctional complexes
- •17.2.4 Lamina propria
- •17.2.5 Intestinal regulatory T cells
- •17.2.6 Intestinal alkaline phosphatase
- •17.2.7 Antimicrobial peptides
- •17.2.8 Lysozyme
- •17.3 Mechanistic view of factors leading to a leaky gut
- •17.3.1 Gut dysbiosis
- •17.3.2 Mucosal inflammation and oxidative stress
- •17.3.3 TJ disruption
- •17.3.4 Genetics
- •17.3.5 Drugs
- •17.4 Pathological implications of a leaky gut
- •17.5 Natural product improving gut microbial dysbiosis
- •17.5.1 Traditional herbs and polyherbal formulations managing gut micro flora
- •17.5.2 Phytocompounds in the management of intestinal barrier integrity through balancing gut microflora
- •17.6.1 Anti-inflammatory traditional medicine and plant extracts ameliorating intestinal mucosal injury
- •17.6.2 Plant active constituents preventing mucosal injury and oxidative damage
- •17.7 Traditional medicine and natural products upregulating the TJ proteins
- •17.7.1 Traditional medicine and herbal extracts promoting junction protein protection
- •17.7.2 Phytocompounds for junction protein protection
- •17.8 Natural products averting pathological conditions through maintaining intestinal barrier function
- •17.9 Conclusion
- •Keywords
- •References
- •18. Role of Natural Products in the Pharmacotherapy of Osteoporosis
- •18.1 Introduction
- •18.1.1 Effect of traditional chinese medicine (TCM)
- •18.1.2 Effect of malay traditional medicine
- •18.1.3 Antiosteoporotic agents extracted from plant sources
- •18.1.4 Treatment by different pigments
- •18.1.5 Other herbal sources
- •18.1.6 Natural plant-based alkaloids
- •18.1.7 Essential markers involved in bone formation and resorption for osteoporosis treatment
- •18.2 Conclusion
- •Keywords
- •References
- •19. Gel-Based Natural Therapeutics: Potential Alternatives to Traditional Drug Delivery Systems in Aquaculture
- •19.1 INtroduction
- •19.2 DDS
- •19.2.1 Water medication
- •19.3 Oral administration
- •19.3.1 Gavage

253
activities and chemical structures, which have a wide range of applications in medicine,
agriculture, and industry. Furthermore, the study of natural products from endophytic
microorganisms has provided valuable insights into the ecological significance of these
microbes in plant-microbe interactions, as well as their potential for sustainable and
eco-friendly agriculture.
The investigation of natural products derived from endophytic microorganisms is a
dynamic and rapidly evolving area of research that holds great promise for addressing
various societal challenges. The continued exploration and exploitation of this eld will
require interdisciplinary collaborations, innovative technologies, and sustainable practices
that consider both the scientic and societal aspects of natural product research and
development.
KEYWORDS
• endophytic microorganisms
• natural products
• endophytic microorganisms
• endophytic fungi
• coculture
REFERENCES
Abba, C.; Eze, P.; Abonyi, D.; Nwachukwu, C.; Proksch, P.; Okoye, F.; Eboka, C. Phenolic compounds from
endophytic Pseudofusicoccum sp. isolated from Annona muricata. Trop. J. Nat. Prod. Res. 2018, 2(7),
332–337.
Abonyi, D.; Eze, P.; Abba, C.; Ujam, N.; Proksch, P.; Okoye, F.; Esimone, C. Biologically active phenolic acids
produced by Aspergillus sp., an endophyte of Moringa oleifera. Eur. J. Biol. Res. 2018, 8(3), 158–168.
Afzal, I.; Shinwari, Z. K.; Sikandar, S.; Shahzad, S. Plant beneficial endophytic bacteria: Mechanisms, diversity ,
host range and genetic determinants. Microbiol. Res. 2019, 221, 36–49.
Aharwal, R. P.; Kumar, S.; Sandhu, S. S. Endophytic mycoflora: Antibacterial secondary metabolites and their
therapeutic potential. Curr. Pharmacol. Rep. 2021, https://doi.org/10.1007/s40495-021-00261-w
Ai, H. L.; Zhang, L. M.; Chen, Y. P.; Zi, S. H.; Xiang, H.; Zhao, D. K.; Shen, Y. Two new compounds from an
endophytic fungus Alternaria solani. J. Asian Nat. Prod. Res. 2012, 14(12), 1144–1148.
Ali, M.; Ali, Q.; Sohail, M. A.; Ashraf, M. F.; Saleem, M. H.; Hussain, S.; Zhou, L. Diversity and taxonomic
distribution of endophytic bacterial community in the rice plant and its prospective. Int. J. Mol. Sci. 2021,
22(18), 10165.
Altomare, C.; Perrone, G.; Zonno, M. C.; Evidente, A.; Pengue, R.; Fanti, F.; Polonelli, L. Biological
characterization of fusapyrone and deoxyfusapyrone, two bioactive secondary metabolites of Fusarium
semitectum. J. Nat. Prod. 2000, 63(8), 1131–1135.
Ambikapathy, V.; Babu, S.; Shanmugapriya, R.; Prakash, A.; Shijila Rani, A. S. Identification of bacterial
endophytes by 16S rRNA. In: Sankaranarayanan, A.; Amaresan, N.; Dwivedi, M. K. (Eds.), Endophytic
Microbes: Isolation, Identification, and Bioactive Potentials. Springer Protocols Handbooks: New York.
2023.

254
Ateba, J.; Toghueo, R.; Awantu, A.; Mba'ning, B.; Gohlke, S.; Sahal, D.; Rodrigues-Filho, E.; Tsamo, E.;
Boyom, F . F.; Sewald, N.; Lenta, B. N. Antiplasmodial properties and cytotoxicity of endophytic fungi from
Symphonia globulifera (Clusiaceae). J. Fungi. 2018, 4, 70.
Azman, A. S.; Othman, I. S.; Velu, S.; Chan, K. G.; Lee, L. H. Mangrove rare actinobacteria: Taxonomy , natural
compound, and discovery of bioactivity. Front. Microbiol. 2015, 6, 856.
Barka, E. A.; Vatsa, P.; Sanchez, L.; Gaveau-Vaillant, N.; Jacquard, C.; Meier-Kolthoff, J. P.; Klenk, H. P.;
Clément, C.; Ouhdouch, Y.; van Wezel, G. P. Taxonomy, physiology, and natural products of actinobacteria.
Microbiol. Mol. Biol. Rev. 2016, 80(4), 1–43.
Bashyal, B. P.; Wellensiek, B. P.; Ramakrishnan, R.; Faeth, S. H.; Ahmad, N.; Gunatilaka, A. A. Altertoxins
with potent anti-HIV activity from Alternaria tenuissima QUE1Se, a fungal endophyte of Quercus emoryi.
Bioorg. Med. Chem. 2014, 22(21), 6112–6116.
Bielecka, M.; Pencakowski, B.; Nicoletti, R. Using next-generation sequencing technology to explore genetic
pathways in endophytic fungi in the syntheses of plant bioactive metabolites. Agriculture. 2022, 12, 187.
Burragoni, S. G.; Jeon, J. Applications of endophytic microbes in agriculture, biotechnology, medicine, and
beyond. Microbiol. Res. 2021, 245, 126691.
Caroll, G. C. The biology of endophytism in plants with peculiar reference to woody perennials In: Fokkenna, N.
J.; Van Den Henvel, J. (Eds.), Microbiology of Phylosphere. Cambridge University Press: Cambridge. 1986,
pp. 205–222.
Chatterjee, S.; Ghosh, R.; Mandal, N. C. Production of bioactive compounds with bactericidal and antioxidant
potential by endophytic fungus Alternaria alternata AE1 isolated from Azadirachta indica A. Juss. PLoS
One. 2019, 14, e0214744.
Cui, R.; Lu, X.; Chen, X.; Malik, W. A.; Wang, D.; Wang, J.; Wang, S.; Guo, L.; Chen, C.; W ang, X.; Wang, X.;
Dai, M.; Ye, W . A novel raffinose biological pathway is observed by symbionts of cotton Verticillium dahliae
to improve salt tolerance genetically on cotton. J. Agron. Crop. Sci. 2021, 207, 956–969.
Das, A.; Rahman, M. I.; Ferdous, A. S.; Amin, A.; Rahman, M. M.; Nahar, N.; Uddin, M. A.; Islam, M. R.;
Khan, H. An endophytic basidiomycete, Grammothele lineata, isolated from Corchorus olitorius, produces
paclitaxel that shows cytotoxicity. PLoS One. 2017, 12, e0178612.
Dhayanithy, G.; Subban, K.; Chelliah, J. Diversity and biological activit ies of endophytic fungi associated with
Catharanthus roseus. BMC Microbiol. 2019, 19(1), 22.
Digra, S.; Nonzom, S. An insight into endophytic antimicrobial compounds: An updated analysis. Plant
Biotechnol. Rep. 2023, 1–31, https://doi.org/10.1007/s11816-023-00824-x
Dogan, G.; Taskin, B. Hydrolytic enzymes producing bacterial endophytes of some Poaceae plants. Pol. J.
Microbiol. 2021, 70(3), 297–304.
Ebada, S.; Eze, P.; Okoye, F.; Esimone, C.; Proksch, P. The fungal endophyte Nigrospora oryzae produces
quercetin monoglycosides previously known only from plants. Chemistry Select. 2016, 1
El-Bialy, H. A.; El-Bastawisy, H. S. Elicitors stimulate paclitaxel production by endophytic fungi isolated from
ecologically altered Taxus baccata. J. Radiat. Res. Appl. 2020, 13, 79–87.
El Enshasy, H. A.; Hanapi, S. Z.; Malek, R. A.; Abdelgalil, S. A.; Leng, O. M. Endophytic fungi: The desired
biostimulants for essential oil production. In: Singh, B. P. (Ed.), Advances in Endophytic Fungal Research:
Present Status and Future Challenges. Springer: Cham. 2019, pp. 211–232.
El-Kassem, L. A.; Hawas, U. W.; El-Souda, S.; Ahmed, E. F.; El-Khateeb, W.; Fayad, W. Anti-HCV protease
potential of endophytic fungi and cytotoxic activity. Biocatal. Agric. Biotechnol. 2019, 19, 101170.
Eze, P.; Abonyi, D.; Abba, C.; Proksch, P.; Okoye, F.; Esimone, C. Toxic, but beneficial compounds from
endophytic fungi of Carica papaya. EuroBiotech J. 2019, 3(2), 105–111.
Fadiji, A. E.; Babalola, O. O. Elucidating mechanisms of endophytes used in plant protection and other
bioactivities with multifunctional prospects. Front. Bioeng. Biotechno. 2020, 8, 467.
Ferreira, M. C.; Cantrell, C. L.; Wedge, D. E.; Gonçalves, V. N.; Jacob, M. R.; Khan, S.; Rosa, C. A.; Rosa, L.
H. Antimycobacterial and antimalarial activities of endophytic fungi associated with the ancient and narrowly
endemic neotropical plant Vellozia gigantea from Brazil. Memórias do Instituto Oswaldo Cruz. 2017, 112,
692–697.
Fleming, A. Nobel Laureate address; 1945. Available online: https://www.nobelprize.org/prizes/medicine/1945/
fleming/speech/ (accessed April 18, 2023).
, 2767 –2771.

255
Gakuubi, M. M.; Munusamy, M.; Liang, Z. X.; Ng, S. B. Fungal endophytes: A promising frontiers for
discovery of novel bioactive compounds. J. Fungi. 2021, 7(10), 786.
Ganapathy, A.; Natesan, S. Metabolic potential and biotechnological importance of plant associated endophytic
actinobacteria. In: Bhim, P. S.; Vijai, K. G.; Ajit, K. P. (Eds.), New and Future Developments in Microbial
Biotechnology and Bioengineering. Elsevier. 2018, pp. 207–224.
Gill, H.; Vasundhara, M. Isolation of taxol producing endophytic fungus Alternaria brassicicola from
non-Taxus medicinal plant Terminalia arjuna. World J. Microbiol. Biotechnol. 2019, 35, 74.
Gouda, S.; Das, G.; Sen, S. K.; Shin, H. S.; Patra, J. K. Endophytes: A treasure house of bioactive compounds
of medicinal importance. Front. Microbiol. 2016, 7, 1538.
Guo, B.; Wang, Y.; Sun, X.; Tang, K. Bioactive natural products from endophytes: A review. Appl. Biochem.
Microbiol. 2008, 44(2), 136–142.
Hardoim, P. R.; van Overbeek, L. S.; Berg, G.; Pirttilä, A. M.; Compant, S.; Campisano, A.; Döring, M.;
Sessitsch, A. The hidden world within plants: Ecological and evolutionary considerations for defining
functioning of microbial endophytes. Microbiol. Mol. Biol. Rev. 2015, 79(3), 293–320.
Heinig, U.; Scholz, S.; Jennewein, S. Getting to the bottom of taxol biosynthesis by fungi. Fungal Divers. 2013,
60(1), 161–170.
Hussein, M. E.; Mohamed, O. G.; El-Fishawy, A. M.; El-Askary, H. I.; El-Senousy, A. S.; El-Beih, A. A.;
Nossier, E. S.; Naglah, A. M.; Almehizia, A. A.; Tripathi, A.; Hamed, A. A. Identification of antibacterial
metabolites from endophytic fungus Aspergillus fumigatus, isolated from Albizia lucidior leaves (Fabaceae),
utilizing metabolomic and molecular docking techniques. Molecules. 2022, 27(3), 1117.
Karunai, S. B.; Balagengatharathilagam, P. Isolation and screening of endophytic fungi from medicinal plants
of Virudhunagar district for antimicrobial activity. Int. J. Sci. Nat. 2014, 5(1), 147–155.
Kaushik, N. K.; Murali, T. S.; Sahal, D.; Suryanarayanan, T. A search for antiplasmodial metabolites among
fungal endophytes of terrestrial and marine plants of southern India. Acta Parasitologica. 2014, 59, 745–757.
Keller, N. P.; Turner , G.; Bennett, J. W. Fungal secondary metabolism from biochemistry to genomics. Nat. Rev.
Microbiol. 2005, 3(12), 937–947.
Khare, E.; Mishra, J.; Arora, N. K. Multifaceted interactions between endophytes and plant: Developments and
prospects. Front. Microbiol. 2018, 9, 2732.
Kim, C. K.; Eo, J. K.; Eom, A. H. Diversity and seasonal variation of endophytic fungi isolated from three
conifers in Mt. Taehwa, Korea. Mycobiology. 2013, 41, 82–85.
Kochhar, N.; Kavya, I. K.; Shrivastava, S.; Ghosh, A.; Rawat, V. S.; Sodhi, K. K.; Kumar, M. Perspectives on
the microorganism of extreme environments and their applications. Curr. Res. Microb. Sci. 2022, 3, 100134.
Kumar, G.; Chandra, P.; Choudhary, M. Endophytic fungi: A potential source of bioactive compounds. Chem.
Sci. Rev. Lett. 2017, 6, 2373–2381.
Kusari, S.; Spiteller, M. Are we ready for industrial production of bioactive plant secondary metabolites
utilizing endophytes? Nat. Prod. Rep. 2011, 28
Lawrence, D.; Vandecar, K. Effects of tropical deforestation on climate and agriculture. Nat. Clim. Change.
2015, 5, 27–36.
Lee, J. C.; Strobel, G. A.; Lobkovsky, E.; Clardy, J. C. Subglutin A and B: Immunosuppressive compounds
from the endophytic fungus Fusarium subglutinans. J. Org. Chem. 1995, 60, 7076–7077.
Li, S. J.; Zhang, X.; W ang, X. H.; Zhao, C. Q. Novel natural compounds from endophytic fungi with anticancer
activity. Eur. J. Med. Chem. 2018, 156, 316–343.
Li, J. Y.; Strobel, G. A. Jestrone and hydroxyl-jesteron anti-oomycetes cyclohexenenone epoxides from the
endophytic fungus Pestalotiopsis jester. Phytochemistry. 2001, 57, 261–265.
Liu, X.; Dong, M.; Chen, X.; Jiang, M.; Lv, X.; Zhou, J. Antimicrobial activity of an endophytic Xylaria
sp. YX-28 and identification of its antimicrobial compound 7-amino- 4- methylcoumarin. Appl. Microbiol.
Biotechnol. 2008, 78, 241–247.
Ma, K. L.; Wei, W. J.; Li, H. Y.; Wang, L. D.; Dong, S. H.; Gao, K. Phomotide A, a novel polyketide, from the
endophytic fungus Phomopsis sp. CFS42. Tetrahedron Lett. 2020, 61, 151468.
Malit, J. J. L.; Leung, H. Y. C.; Qian, P. Y. Targeted lar ge-scale genome mining and candidate prioritization for
natural product discovery. Mar. Drugs. 2022, 20, 398.
Manganyi, M. C.; Ateba, C. N. Untapped potentials of endophytic fungi: A review of novel bioactive compounds
with biological applications. Microorganisms. 2020, 8(12), 1934.
, 1203–1207.

256
Marinho, M. R.; Rodrigues-Filho, E.; Moitinho, R.; Santos, L. S. Biologically active polyketides produced by
Penicillium janthinellum isolated as an endophytic fungus from fruits of Melia azedarach. J. Braz. Chem.
Soc. 2005, 16, 280–283.
Materatski, P .; Varanda, C.; Carvalho, T .; Dias, A. B.; Campos, M. D.; Rei, F.; Félix, M. R. Spatial and temporal
variation of fungal endophytic richness and diversity associated to the phyllosphere of olive cultivars. Fungal
Biol. 2019, 123, 66–76.
Mattoo, A. J.; Nonzom, S. Endophytes: A big boon to agriculture. In: W ani, Z. A.; Qadri, M.; Arora, P.; Hakeem,
K. R. (Eds.), Endophyte Biology: Recent Findings from Kashmir Himalayas. AAP CRS Press Taylor and
Franchise Group: New York. 2021.
Meshram, V.; Gupta, M. Endophytic Fungi: A Quintessential Source of Potential Bioactive Compounds.
Cambridge University Press: Cambridge. 2019.
Ming, Q.; Huang, X.; He, Y.; Qin, L.; Tang, Y.; Liu, Y.; Huang, Y.; Zhang, H.; Li, P. Genome mining and
screening for secondary metabolite production in the endophytic fungus Dactylonectria alcacerensis CT-6.
Microorganisms. 2023, 11(4), 968.
Mishra, V. K.; Passari, A. K.; Leo, V. V.; Singh, B. P. Molecular diversity and detection of endophytic fungi
based on their antimicrobial biosynthetic genes. In: Singh, B. P.; Gupta, V. K. (Eds.), Molecular Markers in
Mycology Fungal Biology. Springer: Cham. 2017, pp. 1–35.
Moussa, M.; Ebrahim, W.; Bonus, M.; Gohlke, H.; Mandi, A.; Kurtan, T.; Hartmann, R.; Kalscheuer, R.; Lin,
W.; Liu, Z.. Co-culture of the fungus Fusarium tricinctum with Streptomyces lividans induces production of
cryptic naphthoquinone dimers. RSC. Adv. 2019, 9, 1491–1500.
Mygind, P. H.; Fischer, R. L.; Schnorr, K. M.; Hansen, M. T.; Sonksen, C. P.; Ludvigsen, S.; Raventos, D.;
Buskov, S.; Christensen, B.; De Maria, L.; T aboureau, O.; Yaver, D.; Elvig-Jørgensen, S. G.; Sørensen, M. V.;
Christensen, B. E.; Kjaerulff, S.; Frimodt-Moller, N.; Lehrer, R. I.; Zasloff, M.; Kristensen, H. H. Plectasin
is a peptide antibiotic with therapeutic potential from a saprophytic fungus. Nature. 2005, 437, 975–980.
Nicoletti, R.; Fiorentino, A. Plant Bioactive Metabolites and Drugs Produced by Endophytic Fungi of
Spermatophyta; 2015. Available online: https://doi.org/10.3390/agriculture5040918 (accessed June 14, 2021).
Nwobodo, D. C.; Ugwu, M. C.; Eze, P. M.; Okezie, U. M.; Okoye, F. B. C.; Esimone, C. O. UV-mediated
enhancement of antibacterial secondary metabolites in endophytic Lasiodiplodia theobromae. Not. Sci. Biol.
2022b, 14(4), 11284.
Nwobodo, D. C.; Eze, P. M.; Okezie, U. M.; Okafoanyali, J. O.; Okoye, F. B. C.; Esimone, C. O. Bioactive
compounds characterization and antimicrobial potentials of crude extract of Curvularia lunata, a fungal
endophyte from Elaeis guineensis. Trop. J. Nat. Prod. Res. 2022a, 6(3), 395–402.
Nwobodo, D. C.; Ihekwereme, C. P.; Okoye, F. B. C. Screening of endophytic fungal metabolites from Cola
nitida leaves for antimicrobial activities against clinical isolates of Pseudomonas aeruginosa. EuroBiotech
J. 2020a, 4(3), 161–166.
Nwobodo, D. C.; Ihekwereme, C. P .; Ikem, C. J.; Okoye, F . B. C. The anti-pseudomonal potentials of metabolites
from some endophytic fungi isolated from Grcinia kola leaves. NRMJ. 2020b, 4(3), 845–855.
Nwobodo, D. C.; Ihekwereme, C. P.; Ugwu, M. C.; Okoye, F. B. C. Screening of endophytic fungal secondary
metabolites from Garcinia kola and Cola nitida for antioxidant properties. OAJPR. 2017, 1(6), 000136.
Pandey, S.; Pandey, S.; Alam, A. Isolation and characterization of endophytic bacteria associated with
gametophytes of bryophytes in Mount Abu (Rajasthan), Rhizosphere. 2022,
Paul, S.; Pratim, C. A. Studies on Endophytic Actinobacteria as Plant Growth Promoters and Biocontrol
Agents. IntechOpen. 2022, doi: 10.5772/intechopen.105169
Petrini, O. Fungal endophyte of tree leaves. In: Andrews, J. H.; Hirano, S. S. (Eds.), Microbial Ecology of
Leaves. Springer: New York. 1991, pp. 179–197.
Petrini, O. T axonomy of endophytic fungi of aerial plant tissues. In: Fokkenna, N. J.; Van Den Henvel, J. (Eds.),
Microbiology of Phylosphere. Cambridge University Press: Cambridge. 1986, pp. 175–187.
Picart, P .; Pirttilä, A. M.; Raventos, D.; Kristensen, H. H.; Sahl, H. G. Identification of novel defensin-encoding
genes of Picea glauca: Isolation and characterization of PGD2, a conserved spruce defensin with strong
antifungal activity. BMC Plant Biol. 2012, 12, 1–14.
Poveda, J.; Baptista, P . Filamentous fungi as biocontrol agents in olive (Olea europaea L.) diseases: Mycorrhizal
and endophytic fungi. Crop. Prot. 2021, 146, 105672.
24, 100592.

257
Poveda, J.; Abril-Urias, P.; Escobar, C. Biological control of plant parasitic nematodes by filamentous fungi
inducers of resistance: Trichoderma, mycorrhizal and endophytic fungi. Front. Microbiol. 2020, 11, 992.
Qiao, W.; Tang, T.; Ling, F. Comparative transcriptome analysis of a taxol-producing endophytic fungus,
Aspergillus aculeatinus Tax-6, and its mutant strain. Sci. Rep. 2020, 10, 1–11.
Rai, N.; Keshri, P . K.; Verma, A.; Kamble, S. C.; Mishra, P.; Barik, S.; Singh, S. K.; Gautam, V . Plant associated
fungal endophytes as a source of natural bioactive compounds. Mycology. 2021, 12(3), 139–159.
Rashmi, M.; Venkateswarasarma, V. Secondary metabolite production by endophytic fungi: The gene clusters,
nature, and expression. Endophytes Second. Metab. 2019, 475–490, https://doi.org/10.1007/978-3-319-
76900-4-20-1
Reen, F . J.; Romano, S.; Dobson, A. D. W.; O’Gara, F. The sound of silence: Activating silent biosynthetic gene
clusters in marine microorganisms. Mar. Drugs. 2015, 13, 4754–4783.
Rezwana, K. Endophytic Fungi from Medicinal Plants for the Production and Characterization of Bioactive
Fungal Metabolites. PhD Thesis. University of Karachi: Pakistan. 2007.
Rigobelo, E. C.; Baron, N. C. Endophytic fungi: A tool for plant growth promotion and sustainable agriculture.
Mycology. 2021, 13(1), 39–55, doi: 10.1080/21501203.2021.1945699.
Rivail, H.; Handayani, D.; Tifani, R. Screening of antimicrobial and cytotoxic activities of endophytic fungi
isolated from mangrove plant Rhizophora mucronata Lam. J. Pharm. Sci. Med. 2018, 3, 9–20.
Rodrigues, K. F.; Hesse, M.; Werner, C. Antimicrobial activities of secondary metabolites produced by
endophytic fungi from Spondias mombin. J. Basic Microbiol. 2000, 40(4), 261–267.
Rodriguez, R. J.; White, J. F.; Arnold, A. E.; Redman, R. S. Fungal endophytes: Diversity and functional roles.
New Phytologist. 2009, 182, 314–330.
Sagita, R.; Quax, W . J.; Haslinger , K. Current state and future directions of genetics and genomics of endophytic
fungi for bioprospecting efforts. Front. Bioeng. Biotechnol. 2021, 9, 649906.
Selim, K. A.; Elkhateeb, W. A.; Tawila, A. M.; El-Beih, A. A.; Abdel-Rahman, T . M.; El-Diwany, A. I.; Ahmed,
E. F. Antiviral and antioxidant potential of fungal endophytes of Egyptian medicinal plants. Fermentation.
2018, 4, 49.
Selim, K. A.; El-Beih, A. A.; Abdel-Rahman, T. M.; El-Diwany, A. I. Biology of endophytic fungi. Curr. Res.
Environ. Appl. Mycol. 2012, 2(1), 31–82.
Shoeb, M.; Haque, M.; Nahar, N. Bioactive compounds from endophytic fungus Penicillium thiomii isolated
from Terminalia chebula Retz. J. Nat. Prod. Plant Resour. 2014, 4, 65–70.
Singh, R.; Pandey, K. D.; Singh, M.; Singh, S. K.; Hashem, A.; Al-Arjani, A. F.; Abd_Allah, E. F.; Singh, P. K.;
Kumar, A. Isolation and characterization of endophytes bacterial strains of Momor dica charantia L. and their
possible approach in stress management. Microorganisms. 2022, 10(2), 290
Singh, S. B.; Ondeyka, J. G.; T sipouras, N.; Ruby, C.; Sardana, V ., Schulman, M.; Lingham, R. B. Hinnuliquinone,
a C2-symmetric dimeric non-peptide fungal metabolite inhibitor of HIV-1 protease. Biochem. Biophys. Res.
Commun. 2004, 324(1), 108–113.
Soliman, S. S. M.; Raizada, M. N. Interactions between cohabitating fungi elicit synthesis of Taxol from an
endophytic fungus in host Taxus plants. Front. Microbiol. 2013, 4, 1–14.
Stelmasiewicz, M.; Świątek, Ł.; Gibbons, S.; Ludwiczuk, A. Bioactive compounds produced by endophytic
microorganisms associated with Bryophytes-The “Bryendophytes”. Molecules. 2023, 28(7), 3246.
Strobel, G. The emergence of endophytic microbes and their biological promise. J. Fungi. 2018, 4, 57.
Strobel, M.; Daisy, B.; Castillo, U.; Harper, J. Natural products from endophytic microorganisms. J. Nat. Prod.
2004, 67(2), 257–268.
Strobel, G.; Ford, E.; Worapong, J.; Harper, J. K.; Arif, A. M.; Grant, D. M.; Fung, P. C. W.; Ming, W.; Chau,
R. Isopestacin, an isobenzofuranone from Pestalotiopsis microspora, possessing antifungal and antioxidant
activities. Phytochemistry. 2002, 60, 179–183.
Stroe, M.; Netzker, T.; Scherlach, K.; Krüger, T.; Hertweck, C.; Valiante, V.; Brakhage, A. A. Targeted induction
of a silent fungal gene cluster encoding the bacteria-specific germination inhibitor fumigermin. Elife. 2020,
9, e52541.
Subbulakshmi, G. K.; Thalavaipandian, A.; Bagyalakshmi, V. R.; Rajendra, A. Bioactive endophytic fungal
isolates of Biota orientalis (L.) Endl., Pinus excels W all and Thuja occidentalis L. Int. J. Adv. Life Sci. 2012,
4, 1–7.

258
Suryanarayanan, T.; Thirunavukkarasu, N.; Govindarajulu, M.; Sasse, F.; Jansen, R.; Murali, T. Fungal
endophytes and bioprospecting. Fungal Biol. Rev. 2009, 23, 9–19.
Suryanarayanan, T.; Venkatesan, G.; Murali, T. Endophytic fungal communities in leaves of tropical forest
trees: Diversity and distribution patterns. Curr. Sci. 2003, 85, 489–493.
Tiwari, P.; Bae, H. Endophytic Fungi: Key insights, emerging prospects, and challenges in natural product drug
discovery. Microorganisms. 2022, 10, 360.
Tshikhudo, P. P.; Ntushelo, K.; Mudau, F. N. Sustainable applications of endophytic bacteria and their
physiological/biochemical roles on medicinal and herbal plants: Review. Microorganisms. 2023, 11(2), 453.
Uzma, F.; Mohan, C. D.; Hashem, A.; Konappa, N. M.; Rangappa, S.; Kamath, P. V.; Singh, B. P.; Mudili, V.;
Gupta, V. K.; Siddaiah, C. N. Endophytic fungi-alternative sources of cytotoxic compounds: A review. Front.
Pharmacol. 2018, 9, 1–37.
Vinu, K.; Krishna, V.; Krishnappa, M. Molecular identification and antibacterial activity of endophytic fungi
Curvularia lunata in W endlandia thyrsoidea (Roth) Steud. of central western Ghats region of Chikkamagaluru,
Karnataka. Int. J. Botany. Stud. 2021, 6(4), 436–439.
Wang, H.; Eze, P.; Hfert, S.; Janiak, C.; Hartmann, R.; Okoye, F.; Esimone, C.; Orfali, R.; Dai, H.; Liu, Z.;
Proksch, P. Substituted L-tryptophan-L-phenyl acetic acid conjugates produced by an endophytic fungus
Aspergillus aculeatus using an OSMAC approach. RSC Adv. 2018, 8, 7863–7872.
Webber, J. A natural control of Dutch elm disease. Nature. 1981, 292, 449–451.
W en, J.; Okyere, S. K.; Weng, J.; Huang, R.; W ang, Y.; Liu, L.; Nong, X.; Hu, Y. Endophytic fungi isolated from
Ageratina adenophora exhibits potential antimicrobial activity against multidrug-resistant Staphylococcus
aureus. Plants. 2023, 12(3), 650.
World Health Organization. WHO Global Report on Traditional and Complementary Medicine 2019. World
Health Organization: Geneva. 2019; Licence: CC BY-NC-SA 3.0 IGO.
Xiang, S.; Liang-Dong, G. Endophytic fungal diversity: Review of traditional and molecular techniques.
Mycology. 2012, 3(1), 65–76.
Yunianto, P.; Rusman, Y.; Saepudin, E.; Suwarso, W. P.; Sumaryono, W . Alkaloid (meleagrine and chrysogine)
from endophytic fungi (Penicillium sp.) of Annona squamosal L. Pak. J. Biol. Sci. 2014, 17(5), 667–674.
Zhang, G.; Sun, S.; Zhu, T .; Lin, Z.; Gu, J.; Li, D.; Gu, Q. Antiviral isoindolone derivatives from an endophytic
fungus Emericella sp. associated with Aegiceras corniculatum. Phytochemistry. 2011, 72(11–12), 1436–1442.
Zhang, H. W .; Song, Y. C.; Tan, R. X. Biology and chemistry of endophytes. Nat. Prod. Rep. 2006, 23, 753–771.
Zhou, J.; Feng, Z.; Zhang, W.; Xu, J. Evaluation of the antimicrobial and cytotoxic potential of endophytic
fungi extracts from mangrove plants Rhizophora stylosa and R. mucronata. Sci. Rep. 2022
, 12, 2733.

CHAPTER 12
Natural Products with Antidiabetic Properties
KANCHAN SINGH
ABSTRACT
Diabetes mellitus (DM) is a medical illness that causes high blood glucose levels, changes
in lipid, carbohydrate, and protein metabolism, and, over time, issues affecting the eyes,
kidneys, cardiovascular system, and neurological system. Numerous plant species from
various geographical places have been investigated for their possible antidiabetic effects.
It is predicted that by 2030, one-third of the global population will be diabetic. While there
are several synthetic medications available on the market to treat DM, long-term use of
these drugs may result in the development of serious negative effects. Medicinal plants are
employed as a source of traditional medicine by around 60% of the world’s population.
DM is treated with a broad variety of plants in the Indian medicinal system, as in other
traditional medical systems around the world. Many herbal remedies help to reduce blood
glucose levels. There is currently a rising interest in investigating these botanical extracts
for potential compounds that could be beneficial in therapeutic situations or that could
elicit unique effects, such as the stimulation of β-cell proliferation. Due to the common
lack of knowledge regarding the extraction methods employed for the active constituents
of these drugs, novel mechanisms, and compounds may potentially be unveiled.
*
*Corresponding author
12.1 INTRODUCTION
Diabetes mellitus (DM) is an endocrine disorder that is not caused by infectious agents.
It is characterized by disruptions in carbohydrate metabolism and is often associated with
hyperglycemia (Kumar et al., 2013). The development of several severe diseases, including
microvascular complications (nephropathy, retinopathy, and neuropathy) and macrovascular complications (peripheral vascular disease and coronary heart disease), has been
associated with this condition (Upendra Rao et al., 2010). According to recent statistics
from the International Diabetes Federation and World Health Organization, the prevalence
of DM has reached a significant number of 246 million individuals globally. Among those
affected, 46% fall within the age range of 40–59 years, which are considered as their most

260
economically productive years. It is projected that this number will rise to a minimum of
380 million by the year 2025 (Sarah et al., 2004). The endocrine function of the pancreas
entails the secretion of insulin and glucagon, which are essential for regulating blood
glucose levels. The secretion of insulin is mediated by islet beta cells and is triggered by
an increase in blood glucose levels. These cells are exclusively responsible for producing
insulin. Anabolic insulin is responsible for regulating the metabolic processes of glucose,
lipid, and protein. The receptors of muscle, liver, and fat cells are bound with insulin. The
reduction of blood glucose levels is achieved through the elevation of glucose absorption
by peripheral insulin-sensitive cells. The aforementioned action leads to an enhancement
in liver glycogenesis and a reduction in pancreatic alpha-cell glucagon secretion, thereby
inhibiting hepatic glucose synthesis through glycogenolysis and gluconeogenesis (Wojcik
et al., 2018). Pancreatic α cells secrete glucagon, a catabolic hormone that counteracts
insulin when blood glucose levels decrease during physical activity or in the intervals
between meals. Glucagon facilitates the process of hepatic and muscular glucose mobilization to sustain the levels of glucose in the bloodstream during periods of fasting (Klein
et al., 1996). Combination therapies are frequently employed to reduce adverse effects and
enhance effectiveness. Examples include the use of sulfonylureas in conjunction with biguanides, as well as thiazolidinedione in combination with glucosidase inhibitors. Synthetic
drugs are associated with several adverse effects, including hypoglycemia at elevated
dosages, diarrhea, lactic acidosis, and hepatic complications (Gupta et al., 2017). The utilization of antidiabetic compounds derived from natural sources presents a promising option
for the management of diabetes, owing to their favorable attributes such as safety , ef ficacy,
accessibility, and cost-effectiveness. Furthermore, the herbal mechanism of action has the
potential to rectify metabolic irregularities and postpone the onset of diabetic complications. Metformin, which is the primary treatment option for type 2 DM, was extracted from
the French lilac plant known as Galega officinalis. This serves as supporting evidence for
the aforementioned concept (Abdel Raoof and Mohamed, 2018).
This chapter is centered on the latest developments in medicinally signicant natural
compounds employed in the treatment of diabetes. The primary focus is on structure–
activity investigations and the elucidation of mechanisms of action of natural products as
antidiabetic agents. Over 800 plants and their bioactive compounds are known to exhibit
antidiabetic properties (Li et al., 2012). This chapter will delve into contemporary advance-
ments in natural products that hold medicinal signicance in the treatment of diabetes
(Sivakumar and Deepa, 2023). The emphasis will be on the structure–activity relationship
and the mechanisms of action of these products. Although antidiabetic medications have
been unable to provide a complete cure for diabetes, they have demonstrated efcacy in
mitigating diabetic complications. The antidiabetic natural products were categorized
based on their respective mechanisms of action (Khan et al., 2019).
12.2 NATURAL PRODUCTS THAT REGULATE GLUCOSE ABSORPTION
This section focuses on the chemical and biological characteristics of natural compounds that
can control α-glucosidase activity. Postprandial hyperglycemia is caused by α-glucosidase,

261
an enzyme that hydrolyzes linear and branched isomaltose oligosaccharides to release
glucose.
12.2.1 SEROTONIN-DERIVED PRODUCTS
Serotonin is a monoamine neurotransmitter that is derived biochemically from tryptophan.
It has been observed that animals, including humans, harbor this substance within their
central nervous system, blood platelets, and gastrointestinal tract. It is also present in
botanical and mycological organisms (González-Flores, 2011). It is essential for sensations
of contentment (Young, 2007).
The investigations report the isolation of two distinct derivatives of serotonin, namely,
N-feruloyl serotonin and N-p-coumaroyl serotonin, from the seeds of safower (Carthamus
tinctorius). The investigations demonstrated the antidiabetic effect of the tested substance
through a more signicant suppression of α-glucosidase activity in comparison to the
positive control, acarbose. Safower is utilized in traditional medicine in Asian and
Korean regions to promote sweating, alleviate constipation, address physical injuries, and
alleviate menstrual discomfort (T akahashi and Miyazawa, 2012). The antidiabetic potential
of safower extract was demonstrated through its ability to enhance insulin secretion in
alloxan-induced diabetic rats (Sabet et al., 2012).
12.2.2 BUTYL-ISOBUTYL-PHTHALATE FROM LAMINARIA JAPONICA
The active compound, butyl-isobutyl-phthalate, derived from Laminaria japonica,
exhibited a hypoglycemic effect on mice with STZ (streptozotocin)-induced diabetes.
This effect was attributed to the inhibition of α-glucosidase activity, as demonstrated in a
laboratory investigation (Akar et al., 2011).
12.2.3 BIOACTIVE COMPOUNDS OF ALLIUM CEPA AND ALLIUM SATIVUM
Garlic, which belongs to the Liliaceae family, is scientifically referred to as A. sativum. A
study has shown that garlic exhibits greater efficacy as an antidiabetic agent compared to
glibenclamide, a widely recognized antidiabetic medication (Eidi et al., 2006). A recent
research study indicated that the utilization of an alcoholic garlic extract resulted in a noteworthy decrease in various biomarkers including aspartate transaminase (AST), alanine
transaminase (ALT), creatinine, urea, total cholesterol, serum triglycerides, and fasting
blood glucose levels. Furthermore, it facilitated the standardization of the functioning of
glucose-6-phosphatase and liver hexokinase (Goel et al., 2012).
Onion (Allium cepa) is a member of the family Liliaceae. Subcutaneous glucose tolerance tests showed that onion bulb ether extract lowered blood glucose levels by lowering
the peak glucose level (J.K. Grover et al., 2002). The primary active compound found
in garlic is allicin, which is accompanied by diallyl disulde. On the other hand, the
primary active compound present in onions is allylpropyl disulde. The aforementioned

262
compounds elicit the secretion of insulin from beta cells located in the pancreas (Yuan and
Bieber, 2003). Each of these bioactive constituents exists in the conguration of cysteine
derivatives, which undergo decomposition via the enzymatic action of allinase, resulting in
the formation of polysuldes and thiosulnates (Yuan and Bieber, 2003).
12.2.4 ELATOSIDES E AND F OF ARALIA ELATA
Elatosides E and F, identified as hypoglycemic agents, were extracted from the roots of
Aralia elata (commonly known as Angelica) of the Araliaceae family. The study demonstrated a noteworthy decrease in blood glucose levels in rats through the implementation of
an oral sucrose tolerance test (Puri et al., 2002). The inhibition of aldose reductase activity
was discovered to be the underlying mechanism behind the antidiabetic properties of the
root, which can be attributed to its biologically active compounds (Guo et al., 2004).
12.2.5 BIOACTIVE COMPOUNDS OF BAUHINIA CANDICANS AND BAUHINIA FORFICATE
The aforementioned botanical specimens are classified under the taxonomic family Caesalpiniaceae. The administration of Bauhinia forficata leaf extracts resulted in a decrease
in total cholesterol, triglycerides, and serum glucose levels in rats with alloxan-induced
diabetes. In addition, the flavonoid kaempferilrin was extracted from the leaves of B.
forficata using butanol and found to exhibit significant antidiabetic properties in alloxaninduced diabetic rats by improving glucose metabolism (Sayago et al., 2013). The leaves
of Bauhinia candicans were found to exhibit strong antidiabetic properties through the
promotion of glucose metabolism, as evidenced by the powerful effects of both butanol and
methanol extracts (Soares et al., 2000).
12.3 NATURAL PRODUCTS THAT ENHANCE INSULIN SENSITIVITY
12.3.1 ASTRAGALUS MEMBRANACEUS POLYSACCHARIDES
The roots of Astragalus membranaceus have exhibited various activities such as immunomodulatory , antihypertensive, antioxidant, and antidiabetic effects (Zheng et al., 2020). The
active polysaccharides present in A. membranaceus were observed to enhance glycemic
control in diabetic rodents by augmenting insulin sensitivity (Zhao et al., 2012).
12.3.2 BIOACTIVE COMPOUNDS OF LITCHI CHINENSIS
The seeds of Litchi chinensis are utilized in traditional medicine to manage gastrointestinal
ailments (Rajagopal and Sasikala, 2008). According to a research, it has been demonstrated
that litchi seeds, containing the compound oligonol, possess a strong antidiabetic effect in
Соседние файлы в папке Библиотека им академика М.И. Перельмана
